Ownership history in CITIGROUP INC · 21 quarters on record
This page tracks every 13F SEC filing in which CITIGROUP INC reported a position in ALX ONCOLOGY HLDGS INC (ALXO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 2,278 | -6,732 | -74.7% | 0.00% | $4K | $1.83 |
| 2025 Q2 | REDUCED | 9,010 | -15,701 | -63.5% | 0.00% | $4K | $0.41 |
| 2025 Q1 | REDUCED | 24,711 | -6,725 | -21.4% | 0.00% | $15K | $0.62 |
| 2024 Q4 | ADDED | 31,436 | +5,884 | +23.0% | 0.00% | $52K | $1.67 |
| 2024 Q3 | ADDED | 25,552 | +17,260 | +208.2% | 0.00% | $47K | $1.82 |
| 2024 Q2 | REDUCED | 8,292 | -35,215 | -80.9% | 0.00% | $50K | $6.03 |
| 2024 Q1 | ADDED | 43,507 | +38,764 | +817.3% | 0.00% | $485K | $11.15 |
| 2023 Q4 | ADDED | 4,743 | +4,220 | +806.9% | 0.00% | $71K | $14.89 |
| 2023 Q3 | REDUCED | 523 | -6,616 | -92.7% | 0.00% | $3K | $4.80 |
| 2023 Q2 | ADDED | 7,139 | +6,214 | +671.8% | 0.00% | $54K | $7.51 |
As of 2025 Q4 — sorted by position size